|Home | About | Journals | Submit | Contact Us | Français|
Giant cell arteritis predominantly affects cranial arteries and rarely involves other sites. We report a patient who presented with small bowel obstruction because of infarction from mesenteric giant cell arteritis. She had an unusual cause of her obstruction and a rare manifestation of giant cell arteritis. In spite of aggressive therapy with steroids, she died a month later because of multiple complications. We discuss the diagnosis and management of small bowel obstruction and differential diagnosis of vasculitis of the gastrointestinal tract. We were able to find 11 cases of bowel involvement with giant cell arteritis in the English literature. This case report illustrates that giant cell arteritis can be a cause of small bowel obstruction and bowel infarction. In the proper clinical setting, vasculitides need to be considered early in the differential diagnosis when therapy may be most effective.
In this case report, we describe a patient who presented with small bowel obstruction. She had an unusual cause of her obstruction, small bowel infarction from giant cell arteritis, and a rare manifestation of giant cell arteritis. Most typically, giant cell arteritis predominantly affects cranial arteries, which leads to headache, scalp and temporal artery tenderness, jaw claudication, and visual disturbances. Systemic symptoms of fever, fatigue, weight loss, myalgias are present in half of patients. Less commonly, it can present as neuropathies, transient ischemic attack, or stroke. Rare manifestations of giant cell arteritis include limb claudication, aortic dissection, myocardial infarction, pericarditis, tongue necrosis, interstitial lung disease, breast mass, or bowel infarction.1,2
The present case reminds us, in the proper setting, to consider giant cell arteritis along with other vasculitic disorders in the differential diagnosis of small bowel obstruction.
A 78-year-old white female with a past medical history significant for migraine headaches, 2 previous abdominal surgeries, and carotid artery disease, presented to the emergency department with a 2-week history of lower abdominal pain and nausea as well as a 4-day history of obstipation. At this time, she denied a new headache or visual symptoms. On examination, she was tachycardic with a heart rate of 126/min and hypertensive with a blood pressure of 151/76 mmHg. Her oral mucosa was dry. Her left pupil was round and reactive to light, while the right was irregular secondary to a recent cataract surgery. Funduscopic examination was not done. She had a diffusely tender abdomen, more so, in the periumbilical region and in the left lower quadrant. Bowel sounds were decreased. The rest of the physical exam was normal. The white blood cell count was elevated at 25.2 k/cumm. The platelet count was mildly elevated at 484 k/cumm. The hemoglobin and hematocrit were normal at 12.7 g/dL and 39%, respectively. Serum lactic acid was normal at 1.1 mg/dL. Other laboratory values were also normal with sodium, 133 meq/L; potassium, 3.5 meq/L; chloride, 90 meq/L; bicarbonate, 30 meq/L; blood urea nitrogen, 17 mg/dL; creatinine, 0.7 mg/dL; alkaline phosphatase, 86 U/L; bilirubin, 0.6 mg/dL; aspartate aminotransferase, 39 U/L; alanine aminotransferase, 21 U/L; lactate dehydrogenase of 190 U/L; amylase, 58 U/L; and lipase, 15 U/L. A plain abdominal film and computerized tomography (CT) scan of the abdomen showed dilated small and large bowel loops. A diagnosis of partial small bowel obstruction was made, and she was treated conservatively.
After 2 days of observation with no clinical improvement, her white blood cell count continued to rise with a left shift, and she also developed rebound tenderness. Repeat CT scan of the abdomen showed multiple fluid and gas filled loops of small bowel without a definite point of obstruction. There was some small bowel wall thickening. There was vascular congestion seen in the mesenteric vessels. Retroperitoneum was unremarkable. There was new development of ascites. There were multiple diverticula in the sigmoid colon as seen previously. She underwent an exploratory laparotomy, and a section of the mid-jejunum was found to be necrotic without perforation. Ninety-nine centimeters of bowel was resected and submitted for pathological examination.
Two days after the surgery, the patient complained of a shade obscuring her vision in her left eye, and on examination, she had decreased visual acuity in that eye. The next day, her vision in that eye deteriorated to only hand movement and then rapidly to no light perception. Funduscopic examination by an ophthalmologist showed left ischemic optic neuropathy and a normal right optic disc. On the same day, the pathological examination of her bowel was reported as giant cell arteritis. On repeated questioning at this time, she reported intermittent blurred vision in her left eye about a week before admission. She also recalled having a severe headache 4 days before admission that was different from her usual migraines, but this was on the right side, opposite to the side of her blindness. Examination of her temporal arteries did not show any thickening or tenderness.
Her erythrocyte sedimentation rate and C reactive protein were 99 mm/hour (normal range, 0–33 mm/hour) and 131 mg/L (normal range, 0–3 mg/L), respectively. As we had a definite pathology, a temporal artery biopsy was not done. She was started on intravenous Methylprednisolone, 24 mg twice daily. A few days later, she was discharged home on Prednisone, 60 mg daily. She did not recover from her visual loss in the affected eye. A month later, she was readmitted with steroid-related complications. She had developed impaired glucose tolerance, proximal myopathy, methicillin sensitive staphylococcus bacteremia, and a decubitus ulcer. Over the next 10 days, her steroid dose was tapered rapidly down to 12.5 mg daily. Despite treatment with antibiotics, nutritional support, and other supportive care, she did not improve and died about 20 days after admission. An autopsy concluded that the cause of death was ischemic heart disease with hypertensive cardiomyopathy. The major vessels of the heart, lungs, kidney did not show any evidence of giant cell arteritis. However, the temporal artery was not examined.
Gross pathology of the small bowel showed focal transmural necrosis and extensive mucosal necrosis. Proximal and distal segments of the involved bowel had viable margins. Histology of the mesenteric vessels showed focal giant cell arteritis. The arteritis was seen involving numerous mesenteric vessels of varying sizes. There was infiltration of the artery walls by multinucleated giant cells and inflammatory cells, predominantly lymphocytes. The lumen of these vessels was significantly narrowed with thrombosis.
Ideally, it would have been desirable to correlate these histological findings with a biopsy of the temporal artery. Unfortunately, the patient’s clinical status did not allow us to do this when the diagnosis was first made. Even if the temporal artery had been examined at autopsy, the findings of giant cell arteritis would likely not have been present after 4 weeks of steroid therapy. While this is a limitation of our report, the classical histological findings along with the sudden blindness strongly support a diagnosis of giant cell arteritis. Sections of the mesenteric vessels in our patient are shown in Figures 1 and and22.
Small bowel obstruction is a common clinical problem that accounts for 12% to 16% of surgical admissions annually. Mechanical causes are the most common with adhesions causing 60% of cases. Other etiologies are malignant tumors (20%), hernias (10%), inflammatory bowel disease (5%), volvulus (3%), and other miscellaneous causes (2%).3 Initial management includes fluid resuscitation, nasogastric decompression, and possibly, broad spectrum antibiotics. It is important to differentiate partial from complete obstruction. Continued passage of stool or flatus and persistence of colonic air 6 to 12 hours after onset of symptoms indicate partial obstruction. CT imaging determines the degree of intestinal collapse distal to the obstruction and may also show a transition zone. The majority of cases of partial small bowel obstruction resolve spontaneously, and therefore, a trial of nonoperative management is appropriate in most cases. Management of complete bowel obstruction is more controversial. A delay of surgery for 12 to 24 hours is reasonable, but the incidence of strangulation and ischemia significantly increases after longer periods of nonoperative management. Some signs indicating infarction are continuous abdominal pain, fever, tachycardia, peritoneal signs, leukocytosis, acidosis, absence of bowel sounds, and blood in stools. However, none of these signs are pathognomonic.
Patients with acute mesenteric ischemia may initially present with relatively benign abdominal findings because peritoneal signs do not develop until transmural bowel necrosis occurs. Acute mesenteric ischemia carries a mortality rate exceeding 70% despite advances in patient management.4 Early recognition and treatment is important for intestinal viability and survival. CT imaging findings, although not specific, may aid in differentiating bowel ischemia from infarction. Some radiographic features that indicate ischemia rather than infarction are bowel wall thinning, dilatation of bowel lumen, and pneumatosis.5 Older patients with comorbid illnesses account for a majority of cases of mesenteric ischemia. Acute occlusion may be related to atherosclerosis, low cardiac output states, cardiac arrhythmias, severe valvular heart disease, aortic or mesenteric dissection, and different types of vasculitis.4,5
Localized vasculitis of the gastrointestinal tract has been reported.6 More commonly, however, it occurs as part of a systemic vasculitis. Polyarteritis nodosa is the vasculitis most frequently associated with abdominal manifestations. Other vasculitides associated with bowel infarction are giant cell arteritis, Churg–Strauss syndrome, rheumatoid vasculitis, Kawasaki disease, Takayasu disease, and Buerger disease.7 Vasculitis should be considered early in the differential diagnosis if the patient is young, has no other predisposing factors for bowel ischemia, and there is evidence for multi-organ involvement. CT imaging findings that suggest vasculitis are skip lesions, involvement of multiple anatomic regions, and evidence of ischemia at various chronological stages. Involvement of duodenum almost always indicates vasculitis. Mesenteric angiography is considered the gold standard for acute mesenteric ischemia and can help differentiate vasculitis from other causes of acute arterial occlusion.
Giant cell arteritis involving the bowel has been reported in a small number of cases. Our PubMed search http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmedNational Library of Medicine and National Institutes of Health (words used: giant cell arteritis, bowel; extracranial giant cell arteritis) revealed 11 cases of bowel involvement with giant cell arteritis in the English literature, the earliest of which was in 1976. Stenwig 8 reviewed 64 cases of extracranial giant cell arteritis before 1976. These were autopsy studies; of the 64 cases with extracranial giant cell arteritis, 13 cases showed mesenteric involvement with 4 of these 13 cases showing intestinal gangrene.
Among the 11 cases since 1976, 9 were biopsy proven in the mesenteric vasculature.8–16 The 2 other cases reported giant cell arteritis in other sites in patients with intestinal infarction, in which the infarction was therefore presumed to be due to giant cell arteritis 17,18 (See Table 1). There are 4 case reports in other languages of mesenteric giant cell arteritis, 2 biopsy proven 19,20 with 2 possible cases. 21,22 Of the 9 biopsy proven cases, 4 patients presented with abdominal symptoms but no symptoms of temporal arteritis (See Table 1). One patient presented with both abdominal pain and throbbing headache, and both the temporal artery and mesenteric vessel biopsy were positive.11 In 2 patients, bowel involvement was the initial presentation; interestingly, temporal artery biopsy was done in spite of no cranial symptoms and was positive for giant cells.8,13 In 2 other patients, however, the mesenteric vessels showed giant cell arteritis, whereas their temporal artery biopsy was negative.9,12 Thus, a temporal artery biopsy cannot reliably exclude giant cell arteritis of the mesenteric artery.
Histologically, giant cell arteritis has a granulomatous inflammation. The lumen is narrowed because of intimal proliferation. The adventitia is infiltrated by mononuclear and occasionally polymorphonuclear cells. The media is dominated by giant cells, which can vary from cells with 2 nuclei to masses with multiple nuclei. An early feature of the inflammation is fragmentation of the internal elastic lamina. An uncommon pattern of inflammation is the absence of granulomas with a mixed inflammatory infiltrate and no giant cells. The presence of fibrinoid necrosis is rare and is an indication to consider a different vasculitis.23
While examination of the affected mesenteric vessels may sometimes not be diagnostic of a specific vasculitic syndrome, our patient showed extensive arteritis with giant cells. Among the vasculitic disorders, giant cells are most commonly seen in giant cell arteritis. Granulomatous inflammation with giant cells can also be seen in other vasculitides, notably Takayasu arteritis and Wegener’s granulomatosis. Our patient, however, did not have other clinical and histological findings to suggest these alternate diagnoses. Giant cells can occasionally be seen in Churg–Strauss and Buergers disease (See Table 2). While Polyarteritis nodosa is the vasculitis most likely to cause abdominal ischemia, it is not a granulomatous disease.
In cases where histology is inconclusive for a specific vasculitic disorder, diagnosis is made on demographic characteristics, site of vessel involvement, and clinical manifestations. Our patient had a granulomatous inflammation with giant cells in the mesenteric vessels. Moreover, she developed ischemic optic neuropathy consistent with cranial arteritis. Based on her age, ethnicity, clinical manifestations, and pathology, giant cell arteritis is the most likely diagnosis.
Steroids are effective treatment for the inflammatory lesion in giant cell arteritis. Cyclophosphamide or other immunosuppressive therapy is typically needed for vasculitis because of polyarteritis nodosa but not giant cell arteritis. In all the cases we reviewed of giant cell arteritis involving the mesenteric artery, the diagnosis was only made postoperatively, and the outcomes were poor. In each case, steroids were started after the diagnosis was made.
This case report, along with a few others in the literature, illustrates that intestinal infarction can occur as a rare manifestation of giant cell arteritis. Thus, vasculitic disorders should be considered in the differential diagnosis of bowel infarction, especially in the absence of other obvious causes. When a definite diagnosis is made, aggressive treatment for the specific disorder should be started.
Potential Financial Conflicts of Interests None disclosed.